Clinica de Oncologia Reichow

Blumenau 89010-340

0 studies enrolling now · 2 studies all time

What they study most

Marginal Zone Lymphoma, Receptors, Fibroblast Growth Factor, Relapsed/Refractory Follicular Lymphoma, Urothelial Cancer

Studies at this site

• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed